- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ASD Accompanied by Moderate to Severe Gastrointestinal Symptoms
Total 4603 results
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Memorial Sloan Kettering Cancer CenterWeizmann Institute of Science; Steba Biotech S.A.Active, not recruitingEsophagogastric Cancer | Moderate to Severe DysphagiaIsrael, United States
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Colombia, Estonia, Japan, Taiwan, Israel, Canada, Lithuania, Argentina, Latvia, Iceland, Mexico
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
Fresenius Kabi SwissBioSim GmbHMerck KGaA, Darmstadt, GermanyCompletedPsoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type PsoriasisUnited States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
AbbVie (prior sponsor, Abbott)Raffeiner GmbHCompletedModerate to Severe Plaque Psoriasis
-
AbbVie (prior sponsor, Abbott)Terminated
-
Novartis PharmaceuticalsCompletedPatients With Moderate-to-severe COPD With Destroyed Lung by TuberculosisKorea, Republic of
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
Dalhousie UniversityAlzheimer Society of CanadaNot yet recruitingModerate to Severe Dementia
-
QRxPharma Inc.CompletedModerate to Severe Postoperative PainUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)Germany
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisChina
-
Abivax S.A.Not yet recruitingModerately to Severely Active Crohn Disease
-
AbbVie (prior sponsor, Abbott)WithdrawnModerate to Severe Chronic Plaque Psoriasis
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
AbbVieTerminated
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot FoundationCompletedModerate to Severe DementiaFrance
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
AcelRx Pharmaceuticals, Inc.CompletedAcute Moderate-to-severe PainUnited States
-
Grünenthal GmbHDepomedTerminatedModerate to Severe Acute Postoperative PainUnited States, United Kingdom, Poland
-
PfizerTerminatedModerate-severe PainUnited States
-
PfizerTerminatedModerate-severe PainUnited States
-
Alimentiv Inc.TakedaNot yet recruitingCrohn Disease | Moderately to Severely Active Crohn's Disease | Disease Crohn
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
Lindner Center of HOPEUniversity of Cincinnati; AbbottCompletedBipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild ManiaUnited States
-
Yonsei UniversityRecruitingModerate to Severe Dry EyeKorea, Republic of
-
Charite University, Berlin, GermanyWyeth is now a wholly owned subsidiary of PfizerUnknownModerate to Severe Active Axial SpondyloarthritisGermany
-
Raphaelle Jaquet-PilloudSwiss Foundation for the Health of Children and AdolescentsCompletedModerate to Severe BronchiolitisSwitzerland
-
Kyowa Kirin Co., Ltd.Active, not recruitingModerate to Severe Systemic SclerosisJapan
-
UCB Biopharma S.P.R.L.CompletedModerate to Severe Psoriasis | Generalized Pustular Psoriasis and Erythrodermic PsoriasisJapan
-
Wenzhou Medical UniversityCompletedEfficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye DiseaseModerate to Severe Dry Eye SyndromeChina
-
University of PadovaUnknownModerate to Severe Psoriasis. | Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.Italy
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Pain Due to Diabetic PolyneuropathyGermany
-
University of Illinois at ChicagoJohnson & Johnson Vision Care, Inc.UnknownModerate to Severe Dry Eye DiseaseUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingModerate to Severe AsthmaUnited States
-
Fresenius Kabi SwissBioSim GmbHCompletedModerate to Severe Rheumatoid ArthritisBulgaria, United Kingdom, Hungary, Czechia, Poland, Germany
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
AstraZenecaRecruitingModerate-to-Severe AsthmaChina
-
University of California, San DiegoMayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University; Brigham and Women's Hospital and other collaboratorsRecruitingModerate to Severe AsthmaUnited States
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
AmgenTerminatedModerate to Severe Rheumatoid ArthritisUnited States, Canada, Puerto Rico
-
AbbVie (prior sponsor, Abbott)University Health Network, TorontoCompletedModerate-to-severe Rheumatoid Arthritis
-
ImmuneMed, Inc.Not yet recruitingModerate to Severe Rheumatoid ArthritisNetherlands
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting